DDE Labs specializes in: Drug Delivery, Device R&D, Proteins, Peptides, Oligonucleotides, Formulation, Analytical, Sustained Release.
DDE Labs, San Diego, CA
Joined October 2012
- Tweets1.1K
- Following257
- Followers342
- Likes41
DDELabs retweeted
Review article:
Immunoliposomes in clinical oncology: State of the art and future perspectives.
[50 days' free access]
authors.elsevier.com/a/1Wl8R…
DDELabs retweeted
[ASAP] Synthesis, Self-Assembly, and Biomedical Applications of Antimicrobial Peptide–Polymer Conjugates ift.tt/2pOeNAK
DDELabs retweeted
SDBN Feed: Top 5 Ways You Can Support the March for Science San Diego via SDBN Blog, News: Spring has become “march season” for me and my family, and much like an accountant during tax season, many personal items have been ... tinyurl.com/y885ox37
DDELabs retweeted
A win for the #T1D community! @US_FDA has approved the @dexcom G6 Continuous Glucose Monitoring (#CGM) System. This is the first approved CGM that can be used with other automated insulin delivery devices and the first approved for children ages 2+! ow.ly/j69H30jd58i
DDELabs retweeted
Last night we hosted a #syndicate event for @Sensulin and heard from CEO @mikemoradi on their development of a glucose-response insulin for Type I & II Diabetes, which may eliminate the need for multiple injections a day. Interested in learning more? angelmd.co/en/syndicates/sen…
DDELabs retweeted
Prediabetes can lead to type 2 diabetes, so take the risk test and download the e-toolkit at diabetes.org today! #DiabetesAlertDay #ADA
DDELabs retweeted
Many people don't know the difference between type 1 #diabetes (#T1D) and type 2 diabetes (#T2D) This #AutoimmuneAwarenessMonth, share this gif and help spread the word: ow.ly/khyP30j2rI1 #DiabetesAwareness
DDELabs retweeted
"Look up at the stars and not down at your feet" - Professor Stephen Hawking
1942-2018 cam.ac.uk/stephenhawking
DDELabs retweeted
The benefits of executive coaching are vast in business culture development and reflect in the desired results from both digital marketing and social media. Learn more>> sandlergroup.net/measuring-e…
DDELabs retweeted
EMA requests a post-approval safety long-term diabetic retinopathy outcome study. Authorities very good at sowing seeds of doubt in PPL #T2D for GLP-1 (MTC, pancreatitis, now retinopathy). Likely more harm then benefit from regulatory road of good intentions xitter.gq/ForTraders/status/9416…
This Post is from a suspended account. Learn more
DDELabs retweeted
The peptide, semaglutide has been approved by FDA for Type II #diabetes xitter.gq/novonordisk/status/938…
#PRESS: Novo Nordisk receives US Food and Drug
Administration (FDA) approval for new product xitter.gq/cards/18ce…
DDELabs retweeted
Berg is partnering with Mass General Hospital, Brigham and Women's Hospital to identify new targets for diagnosis, treatment of Alzheimer's Disease, other neurodegenerative disorders. Learn more . . . ow.ly/Aq8E30hdWAK
DDELabs retweeted
Thank you. Will research, try and recommend to all of my patients if data received is robust, scalable and integrative.
DDELabs retweeted
Mark your calendars for Sept 25-28 and don't forget to register at BoulderPeptide.org! The symposium is only two months away!
DDELabs retweeted
Today we start to look at another #application for #aptamers: Biosensors.
#antibodyalternative
bit.ly/2tMYXe0
DDELabs retweeted
Diabetes could cause up to 12% of US deaths bit.ly/2mAPZZE #diabetes
DDELabs retweeted
Our final (!) #Chemistry #History #OTD tweet-RB Merrifield b 7/15/21: solid-phase #peptide synth.; @NobelPrize 1984
nobelprize.org/nobel_prizes/…
DDELabs retweeted
96 yrs of #insulin science bench to bedside & back #diabetes #liver #muscle #brain #adipose #inflammation @Cell_Metabolism @NatureMedicine
